Criteria Bio Ventures

Overview

Criteria Bio Ventures is a venture capital firm specializing in early-stage biotechnology investments, focusing on novel therapeutics. The firm is based in Barcelona, Spain, and primarily invests in private biotech companies across Europe and North America, with a particular emphasis on Spain and Portugal. Their investment approach is agnostic to modalities and disease areas, aiming to support companies that develop disruptive therapeutic solutions addressing significant unmet medical needs. The firm operates with a patient capital model, providing long-term support to portfolio companies to maximize social impact alongside financial returns. They collaborate closely with entrepreneurs and fellow investors to bring life-changing treatments to patients. Their investment strategy includes backing companies at various stages, from seed to growth, and they have a history of leading and co-leading funding rounds, such as the Series A financing of Aboleris Pharma. Criteria Bio Ventures is part of CriteriaCaixa, the holding company managing the wealth of ”la Caixa” Foundation, one of the largest foundations in the world with over 100 years of commitment to society and healthcare. This affiliation provides Criteria Bio Ventures with a strong legacy and access to a global network of experts, enhancing their ability to support innovative biotech companies effectively.

Investment Focus

• Focus on novel therapeutics
• Address significant unmet medical needs
• Potential to transform patients' lives
• Early-stage biotechnology companies

Portfolio Companies